Company
Otsuka
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
64
55 still marketed
Novel approvals
9
Approvals since 2021
9
Originals and new uses
Phase 3 trials
215
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Simtriyo approved NovelPriority reviewJul 24, 2026
- Voyxact approved NovelBreakthrough therapyAccelerated approvalPriority reviewNov 25, 2025
- Rexulti new use May 9, 2025
- Abilify Maintena Kit new use Mar 28, 2025
- Abilify Asimtufii new use Mar 28, 2025
- Rexulti new use Priority reviewMay 7, 2024
- Rexulti new use Priority reviewMay 10, 2023
- Abilify Asimtufii approved Apr 27, 2023
- Rexulti new use Priority reviewDec 27, 2021
- Mannitol 15% In Plastic Container new use Apr 29, 2020
Drugs in development (5)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
- SEP-363856UlotarontPhase 37 trials
Otsuka · Generalized Anxiety Disorder, Schizophrenia, Major Depressive Disorder
- JNT-517Phase 34 trials
Otsuka · Phenylketonuria (PKU), Phenylketonuria
- OPC-1085ELPhase 31 trial
Otsuka · Open Angle Glaucoma or Ocular Hypertension
- QuabodepistatOPC-167832, QBSPhase 31 trial
Otsuka · Rifampicin-Resistant Pulmonary Tuberculosis, Multidrug-Resistant Pulmonary Tuberculosis
- VIS954Phase 22 trials
Otsuka · Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Inflammatory Skin Diseases
Recruiting Phase 3 trials
Largest first.
- A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety DisorderPivotal-lookingRecruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
NCT07786454 · 1,120 participants (planned) · Start Oct 8, 2026 · Primary completion May 26, 2029
Drug: SEP-363856 · For: Generalized Anxiety Disorder
Sites: Jacksonville, Florida; Orlando, Florida; Jamaica, New York · 4 sites in all
- Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD PatientsPivotal-lookingRecruiting
Otsuka Pharmaceutical Co., Ltd.Otsuka
NCT06931080 · 630 participants (planned) · Start Apr 30, 2025 · Primary completion Dec 2027
Drug: EB-1020 (Centanafadine) 164.4 mg; EB-1020 (Centanafadine) 328.8 mg and 1 more · For: Attention Deficit Hyperactivity Disorder (ADHD)
Sites: Tokyo, Japan
- A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety DisorderPivotal-lookingRecruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
NCT07759128 · 576 participants (planned) · Start Jul 28, 2026 · Primary completion Dec 6, 2028
Drug: SEP-363856 · For: Generalized Anxiety Disorder
Sites: Saraland, Alabama; Tucson, Arizona; Encino, California · 27 sites in all
- A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisPivotal-lookingRecruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
NCT07209761 · 532 participants (planned) · Start Oct 16, 2025 · Primary completion Sep 29, 2028
Drug: Bedaquiline; Quabodepistat and 3 more · For: Rifampicin-Resistant Pulmonary Tuberculosis; Multidrug-Resistant Pulmonary Tuberculosis
Sites: Beijing, China; Fuzhou, China; Shenzhen, China · 42 sites in all
- Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute SchizophreniaPivotal-lookingRecruiting
Otsuka Pharmaceutical Co., Ltd.Otsuka
NCT05325645 · 450 participants (planned) · Start Jul 21, 2022 · Primary completion Sep 2027
Drug: OPC-34712FUM/ Brexpiprazole fumarate; Placebo · For: Acute Schizophrenia
Sites: Kure-shi, Japan
- A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety DisorderPivotal-lookingRecruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
NCT07767903 · 384 participants (planned) · Start Aug 6, 2026 · Primary completion Oct 25, 2028
Drug: SEP-363856; Placebo · For: Generalized Anxiety Disorder
Sites: Phoenix, Arizona; Los Angeles, California; Redlands, California · 21 sites in all
- A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHDPivotal-lookingRecruiting
Otsuka Pharmaceutical Co., Ltd.Otsuka
NCT07086313 · 315 participants (planned) · Start Sep 3, 2025 · Primary completion Aug 2027
Drug: EB-1020 (Centanafadine) low dose; EB-1020 (Centanafadine) high dose and 1 more · For: Attention-Deficit Hyperactivity Disorder(ADHD)
Sites: Sapporo, Japan
- A Long-Term Study of JNT-517 in Participants With PhenylketonuriaPivotal-lookingRecruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
NCT06628128 · 240 participants (planned) · Start Aug 11, 2025 · Primary completion Nov 1, 2027
Drug: JNT-517 · For: Phenylketonuria (PKU)
Sites: Gainesville, Florida; Tampa, Florida; Portland, Oregon · 12 sites in all
- A Long-term Trial of EB-1020 in Adult Patients With ADHDPivotal-lookingRecruiting
Otsuka Pharmaceutical Co., Ltd.Otsuka
NCT06926829 · 180 participants (planned) · Start Jun 25, 2025 · Primary completion Dec 2027
Drug: EB-1020 (Centanafadine) 164.4 mg; EB-1020 (Centanafadine) 328.8 mg · For: Attention Deficit Hyperactivity Disorder (ADHD)
Sites: Tokyo, Japan
- A Long-term Trial of EB-1020 in Pediatric Patients With ADHDPivotal-lookingRecruiting
Otsuka Pharmaceutical Co., Ltd.Otsuka
NCT07087327 · 180 participants (planned) · Start Sep 16, 2025 · Primary completion Aug 2027
Drug: EB-1020 (Centanafadine) low dose; EB-1020 (Centanafadine) high dose · For: Attention-Deficit Hyperactivity Disorder(ADHD)
Sites: Sapporo, Japan
Marketed drugs (55)
Newest FDA action first.
- Jynarque Tolvaptan · 2018
- Simtriyo Centanafadine Hydrochloride · 2026
- Rexulti Brexpiprazole · 2015
- Ringer'S In Plastic Container Calcium Chloride, Potassium Chloride, Sodium Chloride · 1980
- Abilify Maintena Kit Aripiprazole · 2013
- Voyxact Sibeprenlimab-Szsi · 2025
- Dextrose 10% In Plastic Container Dextrose · 1979
- Dextrose 5% In Plastic Container Dextrose · 1971
- Abilify Asimtufii Aripiprazole · 2023
- Abilify Aripiprazole · 2002
- Samsca Tolvaptan · 2009
- Mannitol 15% In Plastic Container Mannitol · 1987
- Busulfex Busulfan · 1999
- Nuedexta Dextromethorphan Hydrobromide, Quinidine Sulfate · 2010
- Dextrose 30% In Plastic Container Dextrose · 1985
- Dextrose 50% In Plastic Container Dextrose · 1982
- Dextrose 70% In Plastic Container Dextrose · 1982
- Dextrose 40% In Plastic Container Dextrose · 1982
- Dextrose 20% In Plastic Container Dextrose · 1982
- Sodium Chloride 0.45% In Plastic Container Sodium Chloride · 1979
- Sodium Chloride 0.9% In Plastic Container Sodium Chloride · 1972
- Lactated Ringer'S In Plastic Container Calcium Chloride, Potassium Chloride, Sodium Chloride, Sodium Lactate · 1976
- Aminosyn-Pf 7% Amino Acids · 1985
- Normosol-R In Plastic Container Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride, Sodium Gluconate · 1975
- Dextrose 5% and Lactated Ringer'S In Plastic Container Calcium Chloride, Dextrose, Potassium Chloride, Sodium Chloride, Sodium Lactate · 1975
- Potassium Chloride 20meq In Sodium Chloride 0.9% In Plastic Container Potassium Chloride, Sodium Chloride · 1988
- Dextrose 5% and Sodium Chloride 0.9% In Plastic Container Dextrose, Sodium Chloride · 1976
- Sterile Water In Plastic Container Sterile Water For Irrigation · 1974
- Aminosyn Ii 10% In Plastic Container Amino Acids · 1991
- Normosol-M and Dextrose 5% In Plastic Container Dextrose, Magnesium Acetate, Potassium Acetate, Sodium Chloride · 1975
- Potassium Chloride 10meq In Dextrose 5% and Lactated Ringer'S In Plastic Container Calcium Chloride, Dextrose, Potassium Chloride, Sodium Chloride, Sodium Lactate · 1988
- Potassium Chloride 20meq In Dextrose 5% and Sodium Chloride 0.9% In Plastic Container Dextrose, Potassium Chloride, Sodium Chloride · 1988
- Potassium Chloride 5meq In Dextrose 5% and Sodium Chloride 0.45% In Plastic Container Dextrose, Potassium Chloride, Sodium Chloride · 1980
- Potassium Chloride 30meq In Dextrose 5% In Plastic Container Dextrose, Potassium Chloride · 1980
- Dextrose 5% and Sodium Chloride 0.45% In Plastic Container Dextrose, Sodium Chloride · 1975
- Lactated Ringer'S In Plastic Container Calcium Chloride, Potassium Chloride, Sodium Chloride, Sodium Lactate · 1986
- Sodium Chloride 0.9% In Plastic Container Sodium Chloride · 1974
- Acetic Acid 0.25% In Plastic Container Acetic Acid, Glacial · 1976
- Ringer'S In Plastic Container Calcium Chloride, Potassium Chloride, Sodium Chloride · 1976
- Physiosol In Plastic Container Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride, Sodium Gluconate · 1978
- Dextrose 5% and Sodium Chloride 0.225% In Plastic Container Dextrose, Sodium Chloride · 1975
- Potassium Chloride 15meq In Dextrose 5% and Sodium Chloride 0.225% In Plastic Container Dextrose, Potassium Chloride, Sodium Chloride · 1980
- Ionosol Mb and Dextrose 5% In Plastic Container Dextrose, Magnesium Chloride, Potassium Chloride, Potassium Phosphate, Monobasic, Sodium Lactate, Sodium Phosphate, Monobasic Anhydrous · 1986
- Sterile Water For Injection In Plastic Container Sterile Water For Injection · 1980
- Normosol-R and Dextrose 5% In Plastic Container Dextrose, Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride, Sodium Gluconate · 1975
- Dextrose 5% and Sodium Chloride 0.3% In Plastic Container Dextrose, Sodium Chloride · 1977
- Sodium Chloride 0.9% In Plastic Container Sodium Chloride · 1980
- Aminosyn Ii 15% In Plastic Container Amino Acids · 1991
- Sterile Water In Plastic Container Sterile Water For Irrigation · 1980
- Dextrose 70% In Plastic Container Dextrose · 1989
- Sterile Water For Injection In Plastic Container Sterile Water For Injection · 1989
- Potassium Chloride 20meq In Plastic Container Potassium Chloride · 1992
- Aminosyn-Pf 10% Amino Acids · 1986
- Glycine 1.5% In Plastic Container Glycine · 1980
- Sorbitol-Mannitol In Plastic Container Mannitol, Sorbitol · 1980
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.